Novitan: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Novitan
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€3.0m
2024 · €3.2m-€183,578
Equity
€5.1m
2024 · €5.0m+€37,577
Cash
€1.6m
2024 · €428,529+€1.2m
Balance sheet total
€9.5m
2024 · €10.8m-€1.3m
Largest movements
Assets
- Current investments -€2.2m
down €2.2m (-100%), from €2.2m to €0
- Cash +€1.2m
up €1.2m (+274%), from €428,529 to €1.6m
mainly Net result for the year (+€3.0m) and Current investments (+€2.2m)
- Receivables within one year -€184,857
down €184,857 (-3.1%), from €6.0m to €5.8m
of which Other amounts receivable: -€125,536
- Tangible fixed assets -€145,852
down €145,852 (-15.4%), from €945,233 to €799,381
of which Furniture and vehicles: -€88,228
Equity and liabilities
- Trade debts -€1.1m
down €1.1m (-48.9%), from €2.3m to €1.2m
- Other debts -€161,749
down €161,749 (-5.1%), from €3.2m to €3.0m
Income statement
- Gross operating margin -€180,385
down €180,385 (-3.6%), from €5.0m to €4.8m
- Staff costs +€102,661
up €102,661 (+10.8%), from €950,368 to €1.1m
- Taxes -€64,224
down €64,224 (-9.9%), from €651,129 to €586,905
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€3.2m
Gross operating margin
-€180,385
Staff costs
-€102,661
Depreciation
+€1,662
Write-downs
-€1,103
Other operating charges
-€19,685
Financial income
+€33,923
Financial charges
+€20,447
Taxes
+€64,224
Result 2025
€3.0m
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€2.0m
Investment
+€2.2m
Financing
-€3.0m
Cash 2024
€428,529
From operations (derived)
+€2.0m
Net result for the year
+€3.0m
Depreciation
+€176,305
Stocks and contracts
-€66,799
Receivables within one year
+€184,857
Deferred charges and accrued income
+€16,325
Trade debts
-€1.1m
Tax, wage and social debts
-€25,929
Other debts
-€161,749
Accrued charges and deferred income
-€3,069
Investment (derived)
+€2.2m
Investment in fixed assets (net)
-€35,662
Current investments
+€2.2m
Financing
-€3.0m
Contributions, distributions and other
-€3.0m
Cash 2025
€1.6m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,794,902 | €9,494,772 | -€1.3m | -12.0% |
| Fixed assets | 21/28 | €949,897 | €809,255 | -€140,643 | -14.8% |
| Intangible fixed assets | 21 | €3,665 | €664 | -€3,000 | -81.9% |
| Tangible fixed assets | 22/27 | €945,233 | €799,381 | -€145,852 | -15.4% |
| Plant, machinery and equipment | 23 | €110,442 | €94,210 | -€16,232 | -14.7% |
| Furniture and vehicles | 24 | €203,345 | €115,118 | -€88,228 | -43.4% |
| Leasing and similar rights | 25 | €0 | - | = | |
| Other tangible fixed assets | 26 | €631,446 | €590,053 | -€41,392 | -6.6% |
| Financial fixed assets | 28 | €1,000 | €9,209 | +€8,209 | +821% |
| Current assets | 29/58 | €9,845,005 | €8,685,518 | -€1.2m | -11.8% |
| Stocks and contracts in progress | 3 | €1,165,336 | €1,232,134 | +€66,799 | +5.7% |
| Stocks | 30/36 | €1,165,336 | €1,232,134 | +€66,799 | +5.7% |
| Amounts receivable within one year | 40/41 | €6,020,851 | €5,835,994 | -€184,857 | -3.1% |
| Trade receivables | 40 | €3,480,849 | €3,421,528 | -€59,321 | -1.7% |
| Other amounts receivable | 41 | €2,540,001 | €2,414,465 | -€125,536 | -4.9% |
| Current investments | 50/53 | €2,200,000 | €0 | -€2.2m | -100% |
| Cash at bank and in hand | 54/58 | €428,529 | €1,603,425 | +€1.2m | +274% |
| Deferred charges and accrued income | 490/1 | €30,290 | €13,965 | -€16,325 | -53.9% |
| Total equity and liabilities | 10/49 | €10,794,902 | €9,494,772 | -€1.3m | -12.0% |
| Equity | 10/15 | €5,021,593 | €5,059,170 | +€37,577 | +0.7% |
| Contributions | 10/11 | €90,000 | €90,000 | = | 0.0% |
| Capital | 10 | €90,000 | €90,000 | = | 0.0% |
| Issued capital | 100 | €90,000 | €90,000 | = | 0.0% |
| Reserves | 13 | €4,845,138 | €4,887,770 | +€42,633 | +0.9% |
| Non-distributable reserves | 130/1 | €9,000 | €9,000 | = | 0.0% |
| Legal reserve | 130 | €9,000 | €9,000 | = | 0.0% |
| Distributable reserves | 133 | €4,836,138 | €4,878,770 | +€42,633 | +0.9% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Investment grants | 15 | €86,456 | €81,400 | -€5,055 | -5.8% |
| Amounts payable | 17/49 | €5,773,309 | €4,435,602 | -€1.3m | -23.2% |
| Amounts payable within one year | 42/48 | €5,770,240 | €4,435,602 | -€1.3m | -23.1% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €2,343,547 | €1,196,587 | -€1.1m | -48.9% |
| Suppliers | 440/4 | €2,343,547 | €1,196,587 | -€1.1m | -48.9% |
| Taxes, remuneration and social security | 45 | €264,944 | €239,015 | -€25,929 | -9.8% |
| Taxes | 450/3 | €143,991 | €88,602 | -€55,389 | -38.5% |
| Remuneration and social security | 454/9 | €120,953 | €150,413 | +€29,460 | +24.4% |
| Other amounts payable | 47/48 | €3,161,749 | €3,000,000 | -€161,749 | -5.1% |
| Accrued charges and deferred income | 492/3 | €3,069 | €0 | -€3,069 | -100% |
| Non-recurring operating income | 76A | €0 | €5,701 | +€5,701 | |
| Remuneration, social security and pensions | 62 | €950,368 | €1,053,030 | +€102,661 | +10.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €177,966 | €176,305 | -€1,662 | -0.9% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €1,103 | +€1,103 | |
| Other operating charges | 640/8 | €9,087 | €28,772 | +€19,685 | +217% |
| Gross operating margin | 9900 | €4,984,279 | €4,803,894 | -€180,385 | -3.6% |
| Operating profit (loss) | 9901 | €3,846,857 | €3,544,685 | -€302,172 | -7.9% |
| Financial income | 75/76B | €54,201 | €88,124 | +€33,923 | +62.6% |
| Recurring financial income | 75 | €54,201 | €88,124 | +€33,923 | +62.6% |
| Financial charges | 65/66B | €23,719 | €3,271 | -€20,447 | -86.2% |
| Recurring financial charges | 65 | €23,719 | €3,271 | -€20,447 | -86.2% |
| Profit (loss) for the period before taxes | 9903 | €3,877,339 | €3,629,537 | -€247,802 | -6.4% |
| Income taxes | 67/77 | €651,129 | €586,905 | -€64,224 | -9.9% |
| Profit (loss) for the period | 9904 | €3,226,211 | €3,042,633 | -€183,578 | -5.7% |
| Profit (loss) for the period to be appropriated | 9905 | €3,226,211 | €3,042,633 | -€183,578 | -5.7% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.